Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LA BICHAT: Atorvastatin in Lacunar Stroke
NCT00163150Phase 4Completed
- Sponsor
- Viatris
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in lacunar stroke (LACI) and Cerebral Small Vessel Disease (CSVD) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Cerebral Vasoreactivity at 3 months, Humeral Vasoreactivity at 3 months and 1 more. Started Jun 2003; status: completed.
02
Drugs
atorvastatin
03
Conditions
lacunar stroke (LACI)Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT00163150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163150.